Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Papers
(The H4-Index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Single breath counting is an effective screening tool for forced vital capacity in ALS46
Theme 12 Clinical Management and Support32
Theme 10 Disease Stratification and Phenotyping of Patients28
ALS incidence and population aging in Northern Italy28
Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls26
Determining the need for caregiver support using ALSFRS-R and its limitations23
A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning22
Neurologists’ understanding of reproductive medicine options for genetic forms of motor neuron disease19
REVEALS—a longitudinal cohort study of multifaceted respiratory assessment in ALS19
ALSUntangled #62: vitamin C17
Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-1217
Expanding the clinical and genetic spectrum of SQSTM1-related disorders in family with personality disorder and frontotemporal dementia17
Stigma experienced by ALS/PMA patients and their caregivers: a mixed-methods study17
A speech-based prognostic model for dysarthria progression in ALS16
The cholesterol depleting agent, (2-Hydroxypropyl)-ß-cyclodextrin, does not affect disease progression in SOD1 G93A mice15
ALSUntangled #66: antimycobacterial antibiotics.15
Primary lateral sclerosis natural history study – planning, designing, and early enrollment15
PROSA—a multicenter prospective observational study to develop low-burden digital speech biomarkers in ALS and FTD15
0.1874577999115